Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    Longevity and Mortality Risk Transfer August 13, 2026By LMI Newsdesk
    Share
    Twitter LinkedIn Email

    Total US individual life insurance new annualised with excess premium rose 3% year over year to $4.7bn in the second quarter of 2026, according to preliminary results from LIMRA’s U.S. Life Insurance Sales Survey. 

    The number of policies sold increased 8% in the second quarter, outpacing premium growth. 

    “The individual life insurance market extended its growth in the second quarter, powered by whole life and variable universal life and an 8% jump in policy sales,” said Bryan Hodgens, Head of Research at LIMRA.  

    “That rise in policy count is a clear signal that more American families are taking steps to protect their financial futures. The value of life insurance is resonating with consumers, and our opportunity—and our responsibility—as an industry is to keep making it simpler for people to get the coverage they need.” 

    Whole life (WL) new annualised with excess premium totalled $1.78bn in the second quarter, up 9% from the prior year and the largest single contributor to overall premium growth. WL also posted the strongest policy growth of any product line, with the number of policies sold up 11% year over year. Six in 10 writers increased premium sales, and about half grew policy count. WL remained the largest product line in the US market, representing 37% of total new annualised with excess premium in the second quarter. 

    “Growth remains concentrated in the final expense market, where relatively new products, digital sales platforms, and expanded distribution networks continue to drive sales and extend the market’s reach,” said Karen Terry, Corporate Vice President and Head of LIMRA Insurance Research. 

    Variable universal life (VUL) new annualised with excess premium rose 11% in the second quarter to $800m — the strongest premium growth rate of any product line. Although only about half of VUL carriers reported premium gains, that group included eight of the top 10 writers. Policy count was essentially flat compared with the second quarter of 2025. Growth was fuelled by continued demand in high-face-amount markets, including the survivorship market, and supported by a sharp rebound in US equity markets. VUL premium represented approximately 17% of the total US life insurance market in the second quarter. 

    Term new annualised with excess premium rose 7% to $829m in the second quarter of 2026. Policy count increased 6% year over year. At least half of carriers reported higher premium sales, and nearly half increased policy sales. The largest gains were supported by online distributors and digital term platforms, underscoring consumer appeal for faster, simpler, and more convenient purchasing experiences. Term new annualised with excess premium accounted for an approximate 18% share of the total US individual life insurance market in the second quarter. 

    After declining since the fourth quarter of 2024, fixed universal life (fixed UL) new premium stabilised in the second quarter. Fixed UL new annualised with excess premium was $240m, even with the prior year, and the number of policies sold edged up 1%. At least half of fixed UL writers, including eight of the top 10, reported premium growth. Expectations that interest rates will remain relatively elevated may be lending support to fixed UL. Fixed UL held a 5% share of new premium. 

    Indexed universal life (IUL) new annualised with excess premium was almost $1.1bn in the second quarter of 2026, down 11% from the prior year — its first decline since the second quarter of 2023. The number of IUL policies sold rose 5% year over year. The premium drop reflects an exceptionally strong comparison quarter: IUL premium had surged 31% in the second quarter of 2025, and the carriers posting the steepest declines this quarter were largely those that recorded outsized gains a year ago. About half of IUL writers, including half of the top 10 carriers, reported premium growth. IUL represented 23% of total new annualised with excess premium in the second quarter. 

    2026 - August Life Insurance News News: August 2026
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026By Chris Wells

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.